Cargando…

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan

Background: Antimicrobial resistance (AMR) represents a significant global public health crisis. Despite ample availability of Gram-positive antibiotics, there is a distinct lack of agents against Gram-negative pathogens, including carbapenem-resistant Enterobacterales, which remains a real threat i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Tetsuya, Darlington, Oliver, Miller, Ryan, Gordon, Jason, McEwan, Phil, Ohashi, Takahisa, Taie, Amer, Yuasa, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494726/ https://www.ncbi.nlm.nih.gov/pubmed/34703834 http://dx.doi.org/10.36469/001c.28327

Ejemplares similares

Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study
por: Matsumoto, Tetsuya, et al.
Publicado: (2022)

An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan
por: Sugai, Motoyuki, et al.
Publicado: (2023)

Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan
por: Sugai, Motoyuki, et al.
Publicado: (2023)

Efficacy of carbapenems versus alternative antimicrobials for treating complicated urinary tract infections caused by antimicrobial-resistant Gram-negative bacteria: protocol for a systematic review and meta-analysis
por: Maeda, Masayuki, et al.
Publicado: (2023)

Comparing the Dosing Period in Package Inserts of Antimicrobial Agents Between Japan and the United States
por: Nishigaki, Tetsuta, et al.
Publicado: (2023)

Rethinking Japan’s Infallibility Principle for a Better Pandemic Response
por: Kaneda, Yudai, et al.
Publicado: (2023)

Prevalence of antimicrobial use and active healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in Japan
por: Komagamine, Junpei, et al.
Publicado: (2019)

Prevalence of and rationale for antimicrobial prescription during ambulatory care visits in Japan: a prospective, multicentre, cross-sectional study
por: Komagamine, Junpei, et al.
Publicado: (2020)

Treatment procedures and associated medical costs of methicillin-resistant Staphylococcus aureus infection in Japan: A retrospective analysis using a database of Japanese employment-based health insurance
por: Yuasa, Akira, et al.
Publicado: (2019)

Antimicrobial and Anti-Biofilm Activities of Citrus sinensis and Moringa oleifera Against the Pathogenic Pseudomonas aeruginosa and Staphylococcus aureus
por: Zubair, Mohammad
Publicado: (2020)

Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study
por: Qiao, Lu-Dong, et al.
Publicado: (2013)

Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe
por: Tacconelli, Evelina, et al.
Publicado: (2019)

Influence of the 2009 financial crisis on detection of advanced pulmonary tuberculosis in Osaka city, Japan: a cross-sectional study
por: Danno, Katsura, et al.
Publicado: (2013)

Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021)

Gram-negative Cranial Bone Flap Infection Treated with Continuous Gentamicin Irrigation: A Case Report
por: Toms, Jamie, et al.
Publicado: (2019)

Early and Appropriate Use of Ceftazidime-Avibactam in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections in the Indian Scenario
por: Swaminathan, Subramanian, et al.
Publicado: (2022)

Evidence-Based Interventions to Reduce the Incidence of Common Multidrug-Resistant Gram-Negative Bacteria in an Adult Intensive Care Unit
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2023)

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
por: Huttner, Angela, et al.
Publicado: (2017)

Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
por: Tingsgård, Sandra, et al.
Publicado: (2023)

Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia
por: Gordon, Jason P., et al.
Publicado: (2023)

Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol
por: Erfani, Yousef, et al.
Publicado: (2016)

High Prevalence of Antibiotic-Resistant Gram-Negative Bacteria Causing Surgical Site Infection in a Tertiary Care Hospital of Northeast India
por: Deka, Sangeeta, et al.
Publicado: (2020)

Assessing the Effectiveness of Antibiotic Therapy Against Common Gram-Negative Bacteria in a Saudi Arabian Hospital Using the Drug Resistance Index
por: Yaseen, Muhammad, et al.
Publicado: (2022)

Did Economic Crisis Affect Mortality Due to Infectious Diseases? Trends of Infectious Diseases Mortality in Greece Before and After Economic Crisis
por: Zilidis, Christos, et al.
Publicado: (2021)

Risk Factors for Infection With Multidrug-Resistant Gram-Negative Bacteria in a Tertiary Care Hospital in Saudi Arabia: A Case-Control Study
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2023)

STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship
por: Tacconelli, Evelina, et al.
Publicado: (2016)

Colistin Resistance Among Multi-Drug Resistant Gram-Negative Bacterial Isolates From Different Clinical Samples of ICU Patients: Prevalence and Clinical Outcomes
por: Panigrahi, Kumudini, et al.
Publicado: (2022)

Antimicrobial Therapy for Pneumonia or Fluid Overload?
por: Mbadugha, Uche J, et al.
Publicado: (2021)

Implementation of Antimicrobial Stewardship in the Healthcare Setting
por: Bankar, Nandkishor J, et al.
Publicado: (2022)

4-Hydroxy-2-nonenal antimicrobial toxicity is neutralized by an intracellular pathogen
por: Tabakh, Hannah, et al.
Publicado: (2021)

Interventions to improve antimicrobial prescribing of doctors in training: the IMPACT (IMProving Antimicrobial presCribing of doctors in Training) realist review
por: Wong, Geoff, et al.
Publicado: (2015)

Tuberculosis among migrant populations in the European Union and the European Economic Area
por: Odone, Anna, et al.
Publicado: (2015)

The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia
por: Burgess, Colleen, et al.
Publicado: (2022)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)
por: Shaw, Evelyn, et al.
Publicado: (2016)

Successful Treatment of Brevibacterium Bacteremia Solely With Antimicrobial Therapy
por: Benson, Charles E, et al.
Publicado: (2021)

Changes in a Single Institution’s Orthopedic Hospitalization Service in Japan Owing to COVID-19 in 2020
por: Bekki, Hirofumi, et al.
Publicado: (2021)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

Prevalence of Bacteria and Antimicrobial Resistance Genes in Hospital Water and Surfaces
por: Aleem, Maira, et al.
Publicado: (2021)

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_achbpl6994cgccn8pgtocn1i10